CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Allgens Medical Technology Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Allgens Medical Technology Co Ltd
#5 Kaituo Road
Haidian District, Room A305
Phone: +86 1056330938p:+86 1056330938 Beijing, BEJ  102609  China Ticker: 688613688613

Business Summary
Allgens Medical Technology Co Ltd is a China-based company principally engaged in the research and development, production and sales of high-end biomedical materials and related medical device products. The Company’s main products are mineralized collagen artificial bone repair products used in orthopedics, oral or plastic surgery, and neurosurgery, including Gejin and BonGold, which are mainly used for filling and regenerative repair of various bone defects in the orthopedics field. Chibei, which are mainly used for filling and regenerating bone defects in oral and orthopedic surgery. And Lurui, which are mainly used for cranial defect filling and regeneration repair in neurosurgery. The Company distributes its products both in the domestic market and to overseas markets.
(Source: N-30D)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
3/31/202412/31/2022Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board GangHu 6/3/2022
Chief Financial Officer, Chief Research & Development Officer TainxiSong 41 8/4/2022 8/4/2022
General Manager MenglongCui 44 6/3/2022 6/3/2022
Secretary of the Board ZhiyeChou 38 2/15/2022 2/15/2022

General Information
Number of Employees: 151 (As of 12/31/2022)
Outstanding Shares: 133,333,334 (As of 3/31/2024)
Shareholders: 10,660
Stock Exchange: SHA
Fax Number: +86 1056330939


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, April 26, 2024